Technology

Rubicon has developed platforms for amplification and standardization of nucleic acids that improve the performance of analytical platforms, including qPCR, microarrays, and next-gen sequencing. Our GenomePlex®, TransPlex®, and MethylPlex™ products enable many critical research and diagnostic applications that were previously impossible or unreliable due to variations in the quantity or quality of the starting research and clinical samples.

Learn more about our technology...

Research Products

We provide custom amplification and biomarker discovery services to the university, government, pharmaceutical and biotechnology markets. We have experience with virtually every source of DNA and application known to genomics and can rely upon this experience to adjust protocols, if necessary, to provide a superior product on a fixed schedule. In addition, we collaborate with companies and researchers who are developing better diagnostic tests for multiple analytes using Q-PCR, microarrays, and next-gen sequencing.

Learn more about our research products...

Diagnostic Products

Rubicon provides GenomePlex reagents and licenses to reference laboratories and diagnostics manufacturers to enable more effective patient testing, for example to facilitate more effective pre-implantation genetic diagnostics and cancer diagnostics.

MethylPlex™ is the diagnostic flagship of the Rubicon amplification platforms. We have discovered and licensed valuable methylation biomarkers to our diagnostic partners, as well as delivered simple, robust, automatable methylation assays for detection and management of cancer.

Learn more about Rubicon diagnostic Products...

Rubicon News